Jazz Pharmaceuticals New Hire Equity Award Letter to Liz Henderson
Contract Categories:
Business Finance
›
Equity Distribution Agreements
Summary
Jazz Pharmaceuticals is offering Liz Henderson equity awards as part of her employment, including $1,400,000 in Restricted Stock Units (RSUs) and $1,400,000 in Performance Stock Units (PSUs) under the company's 2011 Equity Incentive Plan. The RSUs are expected to vest over four years in annual 25% increments, while the PSUs will vest after a performance period, both contingent on continued employment and meeting performance goals. The awards are subject to approval and further details will be provided upon grant.
EX-10.17B 4 jazzq42023ex1017b.htm EQUITY AWARD LETTER Document
Exhibit 10.17B
[JAZZ PHARMACEUTICALS LETTERHEAD]
Liz Henderson
New Hire Equity Award
Dear Liz,
April 4, 2023
Welcome to Jazz Pharmaceuticals. In parallel with your hiring by Jazz Pharmaceuticals Ireland Limited, a member of the Jazz Pharmaceuticals group of companies, you will receive equity awards from Jazz Pharmaceuticals plc in the amounts shown below pursuant to the Jazz Pharmaceuticals plc 2011 Equity Incentive Plan (the “EIP”) and subject to approval by the Compensation and Management Development Committee of the Board of Directors in accordance with the policies and guidelines of Jazz Pharmaceuticals plc.
Value of Restricted Stock Units (“RSUs”): $1,400,000 USD
Value of Performance Stock Units (“PSUs”): $1,400,000 USD
Your equity awards will be subject to the terms of the EIP, as well as your applicable grant notices and award agreements which will be provided to you through E*Trade once the awards are approved and issued.
Your RSUs and PSUs, upon vesting, will be released to you as Jazz Pharmaceuticals plc ordinary shares. The vesting schedule of your RSUs and PSUs will be set forth in your grant notices. We anticipate that (1) your RSUs will have a four-year vesting schedule with annual vesting tranches of 25% subject to your continued employment; and (2) your PSUs will vest following completion of the applicable performance period, subject to your continued employment and satisfaction of performance conditions.
If you have questions, please feel free to discuss them with our Global Head of Total Rewards, Eric Stern.
/s/ LH | 07 April 2023 |
Please initial to acknowledge receipt of this document.